Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James J Harding

Showing results (1-10 of 138) with videos related to

Pageof 14
Sort By:
Future Oncology (London, England)|April 18, 2018
Immune checkpoint blockade in advanced hepatocellular carcinoma: an update and critical review of ongoing clinical trialsJames J Harding
Journal for Immunotherapy of Cancer|August 27, 2025
Immune checkpoint blockade and transarterial chemoembolization in liver-limited hepatocellular carcinoma: new questions at the dawn of a new eraAruj Dhyani, James J Harding
Cancers|April 12, 2022
Advanced Bile Duct Cancers: A Focused Review on Current and Emerging Systemic TreatmentsDarren Cowzer, James J Harding
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2026
Shaping the future of HER2-directed therapy in biliary tract cancerOrla M Fitzpatrick, James J Harding
Translational Gastroenterology and Hepatology|February 1, 2019
Understanding and quantifying the immune microenvironment in hepatocellular carcinomaJuan C Osorio, James J Harding
Hepatobiliary Surgery and Nutrition|September 10, 2014
Predicting responsiveness to sorafenib: can the determination of FGF3/FGF4 amplifications enrich for clinical benefit?James J Harding, Ghassan K Abou-Alfa
Cancer|June 6, 2014
Treating advanced hepatocellular carcinoma: How to get out of first gearJames J Harding, Ghassan K Abou-Alfa
Chinese Clinical Oncology|April 6, 2015
Systemic therapy for hepatocellular carcinomaJames J Harding, Ghassan K Abou-Alfa
The New England Journal of Medicine|March 2, 2012
Vemurafenib sensitivity skin reaction after ipilimumabJames J Harding, Melissa Pulitzer, Paul B Chapman
Hematology/Oncology Clinics of North America|February 29, 2024
Immunotherapy: A Sharp Curve Turn at the Corner of Targeted Therapy in the Treatment of Biliary Tract CancersLayal Al Mahmasani, James J Harding, Ghassan Abou-Alfa
Pageof 14

Showing results (1-10 of 138) with videos related to

Sort By:
Pageof 14
Future Oncology (London, England)|April 18, 2018
Immune checkpoint blockade in advanced hepatocellular carcinoma: an update and critical review of ongoing clinical trialsJames J Harding
Journal for Immunotherapy of Cancer|August 27, 2025
Immune checkpoint blockade and transarterial chemoembolization in liver-limited hepatocellular carcinoma: new questions at the dawn of a new eraAruj Dhyani, James J Harding
Cancers|April 12, 2022
Advanced Bile Duct Cancers: A Focused Review on Current and Emerging Systemic TreatmentsDarren Cowzer, James J Harding
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2026
Shaping the future of HER2-directed therapy in biliary tract cancerOrla M Fitzpatrick, James J Harding
Translational Gastroenterology and Hepatology|February 1, 2019
Understanding and quantifying the immune microenvironment in hepatocellular carcinomaJuan C Osorio, James J Harding
Hepatobiliary Surgery and Nutrition|September 10, 2014
Predicting responsiveness to sorafenib: can the determination of FGF3/FGF4 amplifications enrich for clinical benefit?James J Harding, Ghassan K Abou-Alfa
Cancer|June 6, 2014
Treating advanced hepatocellular carcinoma: How to get out of first gearJames J Harding, Ghassan K Abou-Alfa
Chinese Clinical Oncology|April 6, 2015
Systemic therapy for hepatocellular carcinomaJames J Harding, Ghassan K Abou-Alfa
The New England Journal of Medicine|March 2, 2012
Vemurafenib sensitivity skin reaction after ipilimumabJames J Harding, Melissa Pulitzer, Paul B Chapman
Hematology/Oncology Clinics of North America|February 29, 2024
Immunotherapy: A Sharp Curve Turn at the Corner of Targeted Therapy in the Treatment of Biliary Tract CancersLayal Al Mahmasani, James J Harding, Ghassan Abou-Alfa
Pageof 14